APA

Bolhuis M. S., van Altena R., van Hateren K., de Lange W. C. M., Greijdanus B., Uges D. R. A., Kosterink J. G. W., van der Werf T. S. & Alffenaar J. W. C. (20140108). Clinical validation of the analysis of linezolid and clarithromycin in oral fluid of patients with multidrug-resistant tuberculosis. : Antimicrobial agents and chemotherapy.

Chicago

Bolhuis M S, van Altena R, van Hateren K, de Lange W C M, Greijdanus B, Uges D R A, Kosterink J G W, van der Werf T S and Alffenaar J W C. 20140108. Clinical validation of the analysis of linezolid and clarithromycin in oral fluid of patients with multidrug-resistant tuberculosis. : Antimicrobial agents and chemotherapy.

Harvard

Bolhuis M. S., van Altena R., van Hateren K., de Lange W. C. M., Greijdanus B., Uges D. R. A., Kosterink J. G. W., van der Werf T. S. and Alffenaar J. W. C. (20140108). Clinical validation of the analysis of linezolid and clarithromycin in oral fluid of patients with multidrug-resistant tuberculosis. : Antimicrobial agents and chemotherapy.

MLA

Bolhuis M S, van Altena R, van Hateren K, de Lange W C M, Greijdanus B, Uges D R A, Kosterink J G W, van der Werf T S and Alffenaar J W C. Clinical validation of the analysis of linezolid and clarithromycin in oral fluid of patients with multidrug-resistant tuberculosis. : Antimicrobial agents and chemotherapy. 20140108.